USPTO trademark

QUOVANDI

Opposition periodUSPTOWord markClass 5

"QUOVANDI" is a word mark owned by Merck Sharp & Dohme B.V., filed at the USPTO on March 6, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Merck Sharp & Dohme B.V. portfolioGet this data via the API
Official USPTO record
QUOVANDI trademark as filed
As filed with the USPTO
Status
Opposition period
Since September 29, 2026
Filed
March 6, 2026
Registered
Not yet
Priority date
March 4, 2026
Application no.
99687924
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns QUOVANDI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Merck Sharp & Dohme B.V.

Haarlem, Netherlands

1,705 trademarks in the portfolioView company

Representative

Palak Mayani

Merck & Co., Inc.

Goods and services

What the mark covers

The products and services QUOVANDI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Teas/email correspondence entered
  6. Correspondence received in law office
  7. Teas response to suspension inquiry received
  8. Notification of letter of suspension e-mailed
  9. Letter of suspension e-mailed
  10. Suspension letter written

4 earlier steps on the official record.

FAQ

About QUOVANDI

Who owns the trademark "QUOVANDI"?

The USPTO trademark "QUOVANDI" (application 99687924) is owned by Merck Sharp & Dohme B.V.

What is the status of "QUOVANDI"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull QUOVANDI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d3ecb-0aaf-7558-85bf-4a6eb3562d95
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3ecb-0aaf-7558-85bf-4a6eb3562d95",
  "object": "trademark",
  "mark_text": "QUOVANDI",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99687924",
  "filing_date": "2026-03-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Merck Sharp & Dohme B.V.",
      "entity_id": "ent_019f1c88-62cf-7129-9cd2-817c70bcb6bc"
    }
  ]
}